MARC details
000 -LEADER |
fixed length control field |
01058nam a22001457a 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20151026130410.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
091117t xxu||||| |||| 00| 0 eng d |
080 ## - UNIVERSAL DECIMAL CLASSIFICATION NUMBER |
Universal Decimal Classification number |
54(047.31) |
Item number |
IOMC |
110 ## - MAIN ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
World Health organization |
9 (RLIN) |
589 |
245 ## - TITLE STATEMENT |
Title |
Biphenyl |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc. |
Geneva |
Name of publisher, distributor, etc. |
World Health organization |
Date of publication, distribution, etc. |
1999 |
490 ## - SERIES STATEMENT |
Series statement |
Concise International Chemical Assessment Document |
Volume/sequential designation |
no.6-18 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Biphenyl compounds - Adverse effects |
-- |
Biphenyl compounds - Toxicity |
-- |
Environmental exposure |
-- |
Triazines - Adverse effects |
-- |
Triazines - Toxicity |
-- |
Naphthylamine - Adverse effects |
-- |
Naphthylamine - Toxicity |
-- |
Ethylene glycols - Adverse effects |
-- |
Ethylene glycols - Toxicity |
-- |
Hydrocarbon, Fluorinated - Adverse effects |
-- |
Hydrocarbon, Fluorinated - Toxicity |
-- |
Dose-response relationship, Drug |
-- |
Manganese - Adverse effects |
-- |
Manganese - Toxicity |
-- |
Organotin compounds - Adverse effects |
-- |
Organotin compounds - Toxicity |
-- |
Trialkyltin compounds - Adverse effects |
-- |
Trialkyltin compounds - Toxicity |
-- |
Ethylenediamines - Risk assesment |
-- |
Azo compounds - Risk assesment |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Books |